Literature DB >> 22547964

Management of large and giant vestibular schwannomas.

Irumee Pai, James Bowman, Nick Thomas, Neil Kitchen, Anthony Strong, Rupert Obholzer, Michael Gleeson.   

Abstract

The study was conducted to analyze outcomes following surgical management of large and giant vestibular schwannomas and management options for residual disease. This retrospective case note study includes patients who had undergone microsurgical resection of sporadic, large, or giant vestibular schwannomas from 1986 to 2008. Tumors are classified as large if the largest extracanalicular diameter was 3.5 cm or greater and giant if 4.5 cm or greater. The study included 45 patients (33 large, 12 giant tumors), mean tumor size 4.1 cm. Total excision was achieved in 14 cases (31.1%), near-total in 26 (57.8%), and subtotal in 5 (11.1%). Facial nerve outcome was House-Brackmann Grade I/II in 25 cases (55.6%), III/IV in 16 (35.6%), and V/VI in 4 (8.9%). No recurrence has been detected in those undergoing a complete resection. No residual tumor growth been observed in 15 of 26 who underwent near-total resection (57.7%). Of 11 patients, 10 received further treatment as their residual tumors showed growth. In the subtotal excision group, one patient died, three have demonstrated no growth, and one residual tumor has grown slightly but not required intervention. Optimal management for patients with large or giant vestibular schwannomas has yet to be determined. Management decisions must balance long term function with tumor control.

Entities:  

Keywords:  Large vestibular schwannomas; management; residual disease; stereotactic radiotherapy

Year:  2011        PMID: 22547964      PMCID: PMC3312131          DOI: 10.1055/s-0031-1287680

Source DB:  PubMed          Journal:  Skull Base        ISSN: 1531-5010


  18 in total

1.  New and modified reporting systems from the consensus meeting on systems for reporting results in vestibular schwannoma.

Authors:  Jin Kanzaki; Mirko Tos; Mario Sanna; David A Moffat; Edwin M Monsell; Karen I Berliner
Journal:  Otol Neurotol       Date:  2003-07       Impact factor: 2.311

2.  Management of large vestibular schwannomas by combined surgical resection and gamma knife radiosurgery.

Authors:  Stéphane Fuentes; Yasser Arkha; Grégoire Pech-Gourg; François Grisoli; Henry Dufour; Jean Régis
Journal:  Prog Neurol Surg       Date:  2008

3.  Large vestibular schwannomas treated by Gamma Knife surgery: long-term outcomes.

Authors:  Wen-Yuh Chung; David Hung-Chi Pan; Cheng-Chia Lee; Hsiu-Mei Wu; Kang-Du Liu; Yu-Shu Yen; Wan-Yuo Guo; Cheng-Ying Shiau; Yang-Hsin Shih
Journal:  J Neurosurg       Date:  2010-12       Impact factor: 5.115

4.  Clinicopathological factors related to regrowth of vestibular schwannoma after incomplete resection.

Authors:  Masafumi Fukuda; Makoto Oishi; Tetsuya Hiraishi; Manabu Natsumeda; Yukihiko Fujii
Journal:  J Neurosurg       Date:  2011-01-07       Impact factor: 5.115

5.  Treatment of large and giant residual and recurrent vestibular schwannomas.

Authors:  Ricardo Ramina; Maurício Coelho Neto; Kelly Cristina Bordignon; Tobias Mattei; Rogério Clemente; Paulo Henrique Pires Aguiar
Journal:  Skull Base       Date:  2007-03

6.  Vestibular schwannoma radiosurgery after previous surgical resection or stereotactic radiosurgery.

Authors:  Bruce E Pollock; Michael J Link
Journal:  Prog Neurol Surg       Date:  2008

7.  Correlation of growth factor receptor expression with clinical growth in vestibular schwannomas.

Authors:  Brian F O'Reilly; Ameet Kishore; John A Crowther; Colin Smith
Journal:  Otol Neurotol       Date:  2004-09       Impact factor: 2.311

8.  Expression and clinical significance of Ki-67, oestrogen and progesterone receptors in acoustic neuroma.

Authors:  S Cafer; I Bayramoglu; N Uzum; M Yilmaz; L Memis; K Uygur
Journal:  J Laryngol Otol       Date:  2007-08-01       Impact factor: 1.469

9.  Evaluation of cost effectiveness for conservative and active management strategies for acoustic neuroma.

Authors:  S Verma; R Anthony; V Tsai; M Taplin; J Rutka
Journal:  Clin Otolaryngol       Date:  2009-10       Impact factor: 2.597

10.  Revision surgery for residual or recurrent vestibular schwannoma.

Authors:  Simon Richard Mackenzie Freeman; Richard Thomas Ramsden; Shakeel Riaz Saeed; Firas Qaseem Alzoubi; Ricard Simo; Scott Alexander Rutherford; Andrew Thomas King
Journal:  Otol Neurotol       Date:  2007-12       Impact factor: 2.311

View more
  5 in total

1.  "Large and giant vestibular schwannomas: overall outcomes and the factors influencing facial nerve function".

Authors:  Golda Grinblat; Manjunath Dandinarasaiah; Itzak Braverman; Abdelkader Taibah; Dario Giuseppe Lisma; Mario Sanna
Journal:  Neurosurg Rev       Date:  2020-08-29       Impact factor: 3.042

2.  Tumour resection volumes and facial nerve outcomes for vestibular schwannomas.

Authors:  Jagdeep Singh Virk; Sonal Tripathi; Premjit S Randhawa; Elijah A Kwasa; Nigel D Mendoza; Jonathan Harcourt
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-03-25

3.  Clinical features, microsurgical treatment, and outcome of vestibular schwannoma with brainstem compression.

Authors:  Ali Harati; Kai-Michael Scheufler; Rolf Schultheiss; Albaraa Tonkal; Kamran Harati; Paul Oni; Thomas Deitmer
Journal:  Surg Neurol Int       Date:  2017-04-05

4.  Is staged surgery for giant vestibular schwannomas always better in improving outcome: Needs socioeconomic consideration?

Authors:  Guru Dutta Satyarthee; Sushil Kumar
Journal:  J Neurosci Rural Pract       Date:  2014-10

5.  Development of a model to predict vestibular schwannoma growth: An opportunity to introduce new wait and scan strategies.

Authors:  Mayke A Hentschel; Gerjon Hannink; Stefan C A Steens; Jef J S Mulder; Maroeska M Rovers; Henricus P M Kunst
Journal:  Clin Otolaryngol       Date:  2020-11-06       Impact factor: 2.597

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.